Gene Mutations: Changes at the Molecular Level
A mutation can be defined as
- the process by which a gene changes from one allele to another
- the end result of that allelic change.
Major changes can take
place with only a small rearrangement of base pairs on the DNA strand
itself, either due to errors in DNA replication or from outside damage to
the DNA.
Recall:
adaptation is short-term change (via gene expression) in response to
environmental factors; it does not (usually) involve genetic change.
organic evolution is a shift in allele frequencies in a population
(microevolution) which can ultimately lead to speciation (macroevolution)
under certain circumstances.
- Individuals adapt. (They do not evolve.)
- Populations evolve.
The raw material of evolution is mutation.
Evolution, not adaptation, results from changes in gene frequencies and genetic
composition of the main unit of evolution: the population.
A cistron is the smallest unit of genetic material
which can undergo mutation and still produce a single phenotypic effect.
(It's the functional mRNA equivalent of a gene.)
Key ideas:
- mutations can occur spontaneously due to errors in DNA replication or other
spontaneous DNA damage.
- mutations can be induced by outside factors.
- A mutagen is an agent which increases the frequency of mutagenesis.
(note: a carcinogen is a mutagen that causes a
carcinoma--a cancer of the epithelial tissues)
- germline mutations--mutations affecting the germ cells--are the only mutations with direct evolutionary consequences in animals, which exhibit determinate growth.
- However, in organisms exhibiting indeterminate growth, such as bacteria, protists, plants and fungi, somatic mutations can be passed to succeeding generations under certain circumstances. (You should be able to understand why this is so by recalling their life histories.)
- The cell has biological repair mechanisms that can restore the original
configuration of DNA after mutagenesis.
- Cells lacking certain repair systems have a higher than normal rate of
expressed mutation, as these mistakes are not repaired.
Classes of Mutations
At the DNA level:
- point mutation - a change in a single base pair location. These can be:
- base pair substitution - one base pair is replaced by another
(For example, AT-->GC) Base pair substitutions may be...
- transition mutation - change of one purine/pyrimidine pair to the
other purine/pyrimidine pair. Examples:
- transversion mutation - change of purine/pyrimidine pair to a
pyrimidine/purine pair. Examples:
- AT-->TA
- GC-->CG
- AT-->CG
- GC-->TA
At the protein level, point mutations can be:
- silent or synonymous - triplet code is changed, but the amino acid encoded is the same.
Note that while the terms "silent" and "synonymous" are often used interchangeably, the latter term is more specifically a subset of silent mutations in which the changes takes place in a coding region of the proteome (in an exon).
- missense - codon change alters the amino acid encoded
- conservative - new amino acid is chemically similar to the original
- nonconservative - new amino acid is chemically dissimilar to the original aa
- nonsense - codon changes from an amino acid code to a "stop"
codon, changing the nature of the final protein product.
- frameshift - any addition or deletion which
alters the reading frame (i.e., not in a multiple of three).
THE FAT CAT ATE THE RAT -->delete first "E"--> THF ATC ATA TET HER AT...
- additions or deletions of longer segments of DNA
Here's an overview.
Mutations in coding regions of DNA
Point mutations can alter protein structure simply be coding a different amino acid. But is it not uncommon for a point mutation to affect the exact splicing sites of mRNA processing. If this happens, the mutant protein translated from the mis-spliced mRNA is usually non-functional.
Mutations in non-coding regions of DNA
Mutations at non-coding regions such as
- RNA polymerase binding sites
- enhancer sequences
- ribosome binding sites
- 5' and 3' splice sites
- translational regulators
are less predictable in their effects. Usually, the effect of such a mutation will depend on whether it creates a new or disrupts an existing binding site. These can change gene expression in many different ways (degree of expression, timing of expression, you name it).
But mutations that occur at "spacer" DNA sequences that are neither coding nor regulatory are usually phenotypically neutral, and of no immediate consequence.
At the level of phenotypic expression, mutations can be classified as:
- neutral mutation can be any of the above, and is defined as either
- a mutation that has little or no phenotypic effect, or
- a mutation that does not affect on the Darwinian fitness of the individual carrying it.
- forward: change in phenotype from wild type to mutant
- reverse (= reversion): change phenotype from mutant to wild type
also known as "reversions" or "back mutations".
- exact reversion: AAA --> GAA --> AAA (which is lys-->glu-->lys)
- equivalent reversion: UCC --> UGC --> AGC (which is ser-->cys-->ser)
(equivalent reversion can also occur when the amino acid is altered to one
of the same chemical type as the original, e.g. basic aa --> acidic aa --> basic
aa. When this occurs, the individual expressing the reversion is said to
be pseudo wild type.)
- suppressor: A mutation that occurs at one site and
reverses or partially reverses the effects of a mutation at a completely
different site.
- An intragenic suppressor mutation occurs in the same gene as the original
mutation, but at a different site than the original mutation.
- types of intragenic suppressor mutations:
- frameshift of opposite sign
This occurs at a second site in a gene,
reversing the effects of a frame shift:
e.g. CAT CAT CAT CAT
add base before second site CAT:
CATXCAT CAT CAT CAT --> CAT XCA TCA TCA TCA
- second site missense
-
When a gene mutates at one site and is "distorted" in protein function, a mutation
at a second site in the same gene restores a close approximation of the
wild type protein conformation, allowing normal function.
- An intergenic suppressor mutation occurs at a completely different
locus (in a suppressor gene).
Types of extragenic suppressor mutations often involve concurrent mutations in genes encoding mRNA and tRNA:
- nonsense suppressors
If a mutation has occurred at the mRNA site for a particular codon, then
the nonsense suppressor mutation would occur at the DNA site that encodes
the anticodon for the wild-type tRNA that ordinarily matches up with the
wild type mRNA at that site, causing it to become mutant and able to bind
to the mutant mRNA.
For example, if a tryrosine tRNA undergoes mutation at its anticodon region,
it might be able to bind to a mutant stop codon (that used to encode an
amino acid) on the mRNA and add an amino acid where the original mRNA
mutation would have prevented addition of the amino acid.
- missense suppressor
Not yet fully understood, this happens when an abnormal tRNA causes
the mistaken addition of the wrong amino acid in the growing polypeptide,
such that the effects of a missense mutation are overridden.
- frameshift suppressor
Very rare, this occurs when a four-nucleotide anticodon on a tRNA
is able to read a 4-nucleotide codon on an mRNA, effectively allowing the
added base pair to be "skipped."
- physiological suppressor
A defect in one pathway is circumvented by another mutation which occurs
by opening another pathway to the same end function. (Weird, but true!)
Example: If a mutation occurs such that only half of the normal amount of
a given product is produced, a physiological suppressor mutation might be
one that simply increases the availability and transportability of that
smaller amount of product, preventing any serious deleterious
effect.
What Causes Mutations?
Mutations can be
- spontaneous - arising naturally in the absence of known mutagens. In nature, mutations occur randomly in any type of organism, and are not induced by what Lamarck termed sentiments interieurs ("felt need"). Be sure to read about the Luria and Delbruck fluctuation test, which confirmed this hypothesis.
- induced - these may occur naturally, or may be intentionally produced by treating organisms with mutagens (e.g., ionizing radiation or chemical mutagens)
For example, errors can occur during DNA replication
1. A-C bond accidentally forms
2. repair mechanisms accidentally remove the original base instead of
the wrong base on the new strand, and replace it with the complementary
base.
3. result: base pair substitution.
Mutations can occur naturally in the body via
- depurination in which a the glycosidic bond between a base and deoxyribose sugar (a glycosidic bond) is broken or
disrupted; loss of a G or A is the most common result, resulting in an apurinic site.
At normal body temperature, a mammal cell loses about 10,000 purines per 20-hour cell cycle; repair mechanisms are busy!
- deamination often of cytosine, causing it to change to uracil. The result can be a base pair substitution: G-C pair becomes A-T pair.
- oxidatively damaged bases: free radicals in the cell can chemically alter nitrogenous bases and cause subsequent mispairing.
Mispairing Caused by Base Tautomers
DNA bases exist in one of several forms called tautomers--isomers
differing in the position of their atoms/bonds.
Normal DNA - most bases are in keto form:

More rare are the enol or imino forms, which tend to cause mispairing. The result: a tautomeric shift mutation:

Trinucleotide Repeat Mutations
In some genes, three-nucleotide repeats are normal and expected. But mutations causing expansion of these normal repeats can result in serious disorders. Several heritable diseases are known to be due to such repeats.
Fragile X Syndrome
- This is responsible for the most common form of mental retardation in humans.
- It is caused by expansion of a normal 3-base pair CGG repeat in the FMR-1 gene on the X chromosome, located in a part of the gene that is transcribed, but not translated.
- A FMR-1 gene contains 6 - 54 repeats of this sequence (29 repeats is the most common form).
- Affected individuals have 200-1300 repeats in the region.
- Often, the forebears (e.g., grandparents) of affected individuals have more than normal repeats, but not enough for them to express the condition. It appears that the mere presence of extra repeats fosters additional repeats during DNA replication, causing huge expansion of repeats in the offspring that inherit them. Repeat levels too low to cause expression of the condition, but large enough to foster additional repeats are called premutations.
- Expansion of the tri-nucleotide repeats appears to occur preferentially on the maternally inherited X chromosome (a case of parental imprinting).
- Hence, children are more likely to inherit this from their mothers. Since males must receive their X chromosome from their mother, they are more likely to be affected if the mother has a premutation, as they lack a normal X chromsome to mask the condition.
- Female children who inherit a fragile X chromosome from the mother are likely to receive a normal one from the father (unless we're talking inbreeding). As with any X-linked trait, then, males are more likely to express the condition.
Huntington's Disease
- This neurodegenerative disorder is named after American physician George Huntington who described it in 1872. It is inherited as an autosomal dominant, but is usually not expressed until adulthood.
- The disorder is caused by abnormal expansion of a trinucleotide repeat found in wild type human gene known as the Huntington gene (htt).
- Wild type htt has 27 or fewer repeats. Higher levels, 27–35 repeats are tolerated, and carriers of this allele are unaffected. However, once the number reaches 36-39, variable penetrance begins to appear, with some individuals showing symptoms, and others not. With more than 39 repeats, the trait shows full penetrance.
- As in Fragile X, there is a threshold of repeats that can be tolerated. But when this is exceeded, the person with an above-threshold number of repeats suffers from the disorder.
- This gene may also exhibit some degree of parental imprinting: it is more likely to reside on the chromosomes inherited from the father.
The exact mechanism by which these repeats cause disease is not known, but it is notable that most of them affect the nervous system, causing nerve cell death. It is possible that the repeats affect chromatin structure responsible for silencing transcription of the mutant form of the gene. (Huntington's disease may be caused by a loss-of-function mutation.)
The Wonderful World of Mutagens
Induced mutations can be caused by a variety of mutagens, and
many cause specific mutations. Some regularly mutate DNA "hot spots." These are useful in the laboratory.
Chemical Mutagens
- base modifying agents can actually change the chemical structure
of the nitrogenous bases, resulting in mispairing and other problems.
- base analogs can resemble nucleotides so closely that they replace them in the DNA molecule, but do not pair w/ normal bases. Hence: replication, transcription and translation are disrupted. Two examples are 5-bromouracil and
2-aminopurine.

- some chemical mutagens selectively remove NH3 group from A or C. Result:
mispairing.
- some can add hydrocarbon groups to the bases, also causing mispairing.
- some chemicals act as intercalating
agents,
causing the insertion or deletion of an entire base pair (and hence,
frameshift errors, insertions and deletions, since the fit is not exact).
Some fungi produce
mycotoxins that can be either acutely toxic, or have a more delayed toxicity and be carcinogenic. One mycotoxin in particular, known as
aflatoxin B1 is a powerful depurinating agent that is known to promote carcinogenesis via apurinic mutations. (Vindictive fungi!)
Aflatoxin B1 binds directly to DNA at guanine residues (at the N7 position), breaking them off and creating an apurinic site.
Short-wavelength Ionizing Radiation
Ionizing electromagnetic radiation such as x rays and gamma rays
easily pass through the plasma membrane and into the cell where
they are absorbed by intracellular molecules such as water.
- electrons of the absorbing molecules are boosted to such a high energy state
that they spin out of their orbitals and are lost.
- the remaining particle (often a proton) is a positively charged free radical which is highly unstable and reactive.
- free radicals react energetically with anything nearby, from enzymes to RNA
to DNA. Obviously, reactions with DNA are the most long-lasting (other
reactions usually being more ephemeral in their effect).
- ionizing radiation events such as these can also break the DNA across both
backbones, effectively snapping it in half.
Eukaryotes can repair damage like this during synapsis, when the homologs lie
in close apposition and the DNA can be re-linked by repair mechanisms.
Is meiosis the evolutionary result of a mechanism whose original benefit
was to serve as a repair mechanism?
Who knows? But just to be on the safe side, eat plenty of free radical scavengers
Can't hurt. Might help.
Ultraviolet Radiation
Short wavelength radiation just beyond the visible spectrum can be damaging to DNA. Wear your sunscreen.
Repair Mechanisms
- Damage prevention - The cell has various enzymes that de-tox
potential mutagens before they can act. Superoxide dismutase can change
superoxide free radicals into hydrogen peroxide, which is then broken down
by catalase.
- Excision repair - a variety of enzymes can sense distortion of the
strand, and cooperate to excise the mistake and replace it with a correct
DNA sequence.
UV damage repair
Damage reversal - The pyrimidine dimers mentioned previously can be
excised (at least in E. coli) by an enzyme known as DNA photolyase.
In the dark, the enzyme binds to dimerized thymines. In the presence of
light, the enzyme breaks the dimer bonds with light energy, and then falls
off the broken DNA strand. This has not been found in other organisms,
though different repair enzymes are probablye there.
Fortunately for us (but not for the dermatologists), the cell has UV repair
systems. Enzymes can either:
- endonuclease detects a dimer, and makes a "nick" in the
DNA strand on either side of the dimer, 8 phosphodiester bonds upstream of
the dimer, and five phosphodiester bonds downstream from the dimer.
DNA helicase II releases the whole segment, which is degraded. DNA
polymerase I and ligase then fill in the gap.
In prokaryotes and some simple eukaryotes, an enzyme known as photolyase splits photodimers, restoring original
base configuration.
AP repair - this is the repair of apurinic and apyrimidinic sites on
the DNA, where a base has been removed (either by a mutagen or by DNA
glycosylase, which senses a wrong base). AP endonucleases then initiate
repair at the site of excision: Class I endonucleases nick the 3' side of
the site; Class II endonucleases nick the 5' side of the site.
Exonucleases removes the nicked out section, which is then
repaired/replaced by DNA polymerase I and ligase. Have a look:

Postreplication Repair
- If DNA polymerase III encounters a mutation that it cannot polymerize
through (such as a thymine dimer), it skips that area, leaving a broken
piece.
- A group of enzymes repairs this gap in a process known as postreplicative
repair.
- Mismatch repair - This is responsible for about 90% of all DNA repair,
usually due to mismatching during replication.
A mismatch repair system, enzymes encoded by a
series of genes, zip along behind the replication fork, removing incorrect
bases, and able to distinguish between the new and old strands because
only the OLD strand is methylated.
The genes encoding
these enzymes are called mut genes, which is short for "mutator"
genes because when these genes mutate, it results in an unusually high
level of mutation in the cell (due to faulty repair!).
One model--the SOS System--has been studied in E. coli. (It
apparently does not exist in more recently evolved eukaryotes, such as
mammals.)
In this model, of the most important enzymes in this group is one encoded by a gene
called recA. The enzyme product of the gene (RecA) is instrumental in the
SOS response of E. coli,
which is a "stop gap" measure taken by the cell to survive a lethal
mutation while repair takes place, or to accept a non-lethal level of
mutation instead of just succumbing.
The other player in this drama is a gene called lexA, which encodes
a protein known as LexA.
Under normal conditions, LexA squats on the promoter region of a
polycistronic region of about 18 genes (including its own), all of which are involved in the
repair of DNA damage of various types.
In the presence of single stranded DNA (caused by the deletion of bases or
series of bases), RecA somehow becomes activated, and binds to LexA,
causing it to release its hold on the 18 repair genes.
The genes on this area all have a consensus sequence known as the SOS
box: 5'-CTG--ten bases--CAG-3'.
All genes having an SOS box are transcribed, once LexA releases the promoter.
Over time, the damage is repaired.
In the absence of single stranded DNA, RecA loses its activity, and stops
reacting with LexA.
This means that newly manufactured LexA can now diffuse back onto the
operator region of the 18-gene area, and stop transcription of the
emergency repair enzymes.
Here's the scenario:

Interesting side note: the lambda prophage (a virus) also exhibits the SOS
response. It enters a vegetative state when exposed to UV. When this
happens, RecA in the HOST cell also inactivates the prophage's repressor
protein, which is normally preventing transcription of repair enzymes.
The "parasitic" phage utilizes the host's repair enzymes to activate its
own system!
Somatic versus Germline Mutations
- In animals, only germline mutations can be passed on to future generations. Somatic mutations can result in phenotypes from differing color patches to cancer. But because animals exhibit determinate growth, the germline is fixed at early embryogenesis. Somatic cells cannot give rise to the next generation.
- In plants, protists and fungi, somatic mutations can be passed on, since
these organisms exhibit indeterminate growth, and have tissues that can
potentially develop into germinal cell lines throughout the life cycle.
Some non-lethal mutations can be dominant over the wild type
allele. These changes, known as gain-of-function mutations, can produce
new phenotypes that are then subject to the same natural selection as any
other allele.
Various types of mutation can be studied because of their effect on
- Morphology (morphological mutations)
- Viability (lethal mutations)
Note: This feather mutation


Might ordinarily be considered deleterious. But it all depends on context, as we'll see later.
- Biochemical pathways (biochemical
mutations)
- Phenotype in combination with environmental conditions (conditional
mutations)
. A conditional mutation is one which produces different phenotypes in its bearers,
depending upon environmental conditions.
- restrictive conditions - defined as those which result in mutant
phenotype in an organism having the particular conditional mutation.
- Permissive conditions - defined as those which result in wild-type
phenotype in an organism having the particular conditional mutation.
The organism that has this mutation is known as a conditional mutant.
Example: heat sensitive lethal mutations in Drosophila. These types of
mutants are useful for study, since they can be raised in permissive
conditions, then switched to restrictive conditions in order to study the
actual gene expression/protein consequences of the mutation when the
environment changes.
The Genetics of Cancer
Regulation of cell number and division
Key Ideas
The cells of more derived eukaryotes contain mechanisms that control
their survival and ability to proliferate.
These cells constantly evaluate their own condition via continuous
communication among neighboring cells and tissues. Survival and
proliferation controls are highly integrated and dependent on these
inter-cellular communications.
A normal cell's proliferation is regulated at the level of the cell
cycle (mitosis).
Apoptosis (from the Greek apo meaning "from, or away" and
pto meaning "fall"), or programmed cell death, (The word is pronounced ah poh toh' sis, NOT
a pop toh' sis; the second "p"
is silent.) is a normal process by which cells are
destroyed by intra- and extra-cellular mechanisms.
Cells may be triggered into an apoptotic cycle if they are damaged,
dangerously abnormal, or needed only transiently during development.
Intercellular signaling systems allow organized cell proliferation and
apotosis to proceed within any given population of cells.
In cancer cells, proliferation and apoptosis mechanisms have failed
due to mutations in normal tumor-suppressing genes,
preventing self-destruct mechanisms from operating. Cancer cells are
immortal and highly proliferative.
Many of the genes in which mutations cause cancer are those which
contribute either directly or indirectly to the normal control of growth
and differentiation mechanisms in the cell.
Early detection and treatment of cancer is becoming more
sophisticated with the application of functional genomics (i.e.,
discovering not only what genes are in the genome, but what they code
for).
To understand what happens when a Cell Goes Bad, we must first understand
the behavior of a Nice, Normal Cell....



Normal cell proliferation is necessary for
- growth and development (stem cells are totipotent)
- totipotent stem cells can develop into an entire, new organism
- pluripotent stem cells can develop into the three germ layer cell types, but cannot give rise to an entire organism.
- multipotent stem cells can give rise to several cell types, but these are limited in variety. (e.g., haematopoietic blood stem cells)
- replacement of destroyed cells
Cell death is necessary for
- removal of cells not needed after a certain point in
development
- removal of potentially dangerous damaged cells
Cell proliferation and cell death balance one another, and when
mechanisms controlling either or both go awry, neoplasia (from the
Greek neo meaning "new" and plas meaning "form" or
"shape") can result.
Cell Proliferation
Recall that mitosis consists of
- M phase (active mitosis)
- G1 phase (pre DNA synthesis)
- S phase (DNA synthesis)
- G2 phase (post DNA synthesis)
Of these, only the G1 phase is variable in length, mainly because of the
variation in an optional resting phase known as G0.
The cell must pass through checkpoints--fail-safe mechanisms that won't
allow the cell to proceed to one phase until all the parts of the previous
phase are complete--during the cell cycle.
Enzymes involved in the proliferation process are
- protein kinases - phosphorylate specific amino acid residues on
target proteins
- cyclins
- cyclin-dependent protein kinases (CDK proteins)
- protein phosphatases - remove phosphates from specific amino acid
residues on target proteins
- Cyclical variation in the phosphorylation/dephosphorylation of
these key proteins determine which ones are active for each portion of
the cell cycle.
Cell Death
In multicellular organisms, programmed cell death occurs primarily
in somatic cells.
cell proliferation replaces somatic cells lost to cell death.
mechanisms have evolved to eliminate certain cells, and the
process of such programmed cell death is known as apoptosis.
Enzymes & cells involved in apoptosis are
- caspases - disrupt structural and functional systems of the
target cell
- scavenger cells - engulf and remove the "carcasses" of cells that
have undergone apoptosis
The cell must respond to internal and external environmental cues to know
when to proliferate and when to die. These consist of
intercellular chemical signals
receptors of those signals
transduction systems that relay the signal from receptor to other
parts of the cell
Cyclins
exist in families of related enzymes, each of which is present
only during a specific phase of the cell cycle.
are generated by the previous phase's specific cyclin-CDK complex,
which acts as a transcription factor for its gene activation
don't last long in the cell. One type is rapidly degraded and replaced
by the next via
- quick inactivation of the transcription activator for a
particular cyclin's gene (no transcription, no translation)
- instability of cyclin mRNA (easily degraded by nucleases)
- instability of cyclin protein itself
CDK
- Definition: A kinase is an enzyme that phosphorylates proteins.
- Definition: A cyclin-dependent kinase (CDK) is activated specifically by cyclin, which binds to it.
- The cyclin component of a cyclin-CDK complex determines the
target protein of that particular cyclin-CDK. (the cyclin component binds the
protein, and the kinase component phosphorylates it.)
- phosphorylation is transient and reversible
Variations in cyclin-CDK follow the cell cycle...
One example of a well-known transcription factor activation is the Rb/E2F
protein regulation of the G1 to S phase transition in mammals cells...

Apoptosis
This is sometimes referred to as "programmed cell death" and it is
triggered by a variety of signals. It involves...
Proliferation vs. Apoptosis Controls
These are interrelated, and may induce apoptosis in cells
that fail to successfully complete some phase of cell cycle.
Intracellular signals
cell cycle negative controls: inhibition of CDK-cyclin (see
illustration below)
cell cycle positive controls: activation of CDK-cyclin
mitogens are polypeptide ligands (signals released from a nearby
(paracrine) source and received by
plasma membrane receptors). Some of these are growth factors that
activate receptor tyrosine kinases (RTK proteins). This initiates a
signal cascade that affects the configuration of many different
transcription factors, affecting the gene activity in the cell
apoptosis positive controls: leakage of cytochrome c from defective
mitochondria acts as a trigger for apoptosis
apoptosis negative controls: proteins such as Bcl-2 and Bcl-x block
the release of cytochrome c from mitochondria, possibly stabilizing the
mitochondrial membrane and preventing its rupture). This maintains the
apoptosis system in "off" mode
Extracellular signals
based on cell-cell communication
secreted molecules (paracrine signals act locally, are not sent via
circulatory system)
direct cell-cell contact
An example of inhibitory control:
1. DNA is damaged by some mutagen during G1
2. This inhibits the activity of CDK-cyclin complexes
3. The protein responsible for this inhibition is named p53 (and the gene
that encodes it, p53); it senses mismatches in the DNA strand.
4. In the presence of such mismatches, p53 protein activates another
protein named p21 (encoded by a gene named p21).
5. When p21 is present in high concentration, it binds to CDK-cyclin
complexes in the cell, inhibiting their kinase activity and preventing
phosphorylation of proteins.
6. Without proper protein phosphorylation, the cell cycle cannot
continue until DNA mismatches have been repaired.
7. Inhibitory processes are reversed once the DNA mismatches are repaired,
as p53 levels drop in response to lowered levels of DNA mismatches.
8. As p53 levels drop, the binding capacity of p21 also drops.
9. As p21 levels drop, these proteins diffuse off the cyclin-CDK
proteins, which then can resume their normal activity.

Mutations in the genes encoding any of these highly specific "tumor
suppressor" genes can result in cancer.
Cancer cells are
- immortal (do not undergo apoptosis)
- highly proliferative
- clonal (usually derived from a single aberrant Founder Cell)
- malignant/invasive
Many different cell types can be altered to become cancerous. What are the
common threads uniting them?
A cancer cell can be considered an aberrent cell with an accumulation
of mutations that cause it to lose its proliferation and apoptotic
controls. (In other words, a single mutation in a cell is not likely to
cause it to become cancerous.) A cell that has a mutation preventing
apoptosis will have more time to accumulate proliferation-promoting
mutations that will cause it to become cancerous.
Some such mutations can be inherited via the germline (as in
familial/heritable cancers)
- Not all these genes have full penetrance: individuals having the
mutations do not always develop the predicted cancers.
Others can arise de novoin the somatic cell lineage of a
particular cell due to mutagenesis.
- which suggests that the fewer carginogens to which an organism is
subjected, the lower its likelihood of developing cancers
Two major types of mutations are associated with carcinogenesis. Mutations
in
- Oncogenes
- Tumor-suppressor genes
Oncogenes
An oncogene is a dominant mutant gene that contributes to the formation of
(animal) cancer.
The non-mutant form of an oncogene is known as a proto-oncogene.
- These usually encode a protein active only when proper regulator
signals activate them.
- Often, these are proteins involved in positive control pathways.
- Other proto-oncogenes encode negative controls of the apoptotic
pathway.
- The mutation of an oncogene uncouples the activity of a protein
from its normal regulatory function.
- This causes unregulated proliferation and no apoptosis of affected
cells.
Oncogenes have been isolated from certain viruses known
to have carcinogenic activity.
About 100 different oncogenes have thus far been identified.
Oncogenes can change due to
Tumor Suppressor Genes
These are genes that encode an active form of protein that ordinarily
functions to maintain normal proliferation (e.g., rb; a mutant form
of this gene encodes a mutant, non-functional RB protein, and cells containing
this mutation proliferate out of control.
Example:
Retinoblastoma, a cancer of the
retina usually expressed in childhood, is often caused by a somatic
rb mutation. Patients with this form of the cancer usually express
it sporadically, and not in many areas. Very early diagnosis and enucleation
can effect a cure.
Another form of retinoblastoma (HBR) is heritable. People who have
inherited this form have the mutation in many cells, and suffer from
tumors throughout the body, as well as both eyes. In this form,
enucleation of the eye(s) is pointless, as tumors arise in many other
locations.
- mutant rb cells either carry two copies of a gene with the same
mutation, or heterozygous for two different mutations of the same
rb gene, meaning that the mutation is recessive.
- Strangely enough, though, HBR is passed along as if it were autosomal
dominant. How can this be?

If the mutation is inherited via the germline, mitotic crossing over (not
uncommon during development) will result in at least some retinal cells
will acquire two mutant copies of the gene, resulting in retinoblastomic
cells.
Recall the activity of Rb protein, to see how this can be a problem!
Other tumor suppressor mutations involve problems with positive regulation of apoptosis
(e.g., p53).
- Mutations of p53 are associated with many different types
of cancers.
- p53 is thus considered a TUMOR SUPPRESSOR GENE
- Normal P53 protein is a transcription factor activated in response
to DNA damage.
- prevents progression of cell cycle in the presence of damaged DNA
- can induce apoptosis under some circumstances
- Mutant p53 cannot induce apoptosis, and cannot halt the cell
cycle in the presence of damaged DNA.
- This results in an increase in the overal frequency of mutations
- If some of those mutations occur in proteins regulating
proliferation and apoptosis, CANCER will result.
- carcinogenesis of p53 causes cancer indirectly, as it simply
causes an elevated rate of retained mutation, increasing the chances of
carcinogenic mutations.
Mutations of any of these genes result in inactive forms of the protein, allowing
uncontrolled proliferation and/or lack of apoptosis.
Tumor suppressor mutations are generally recessive.
Tumor-promoting mutations were first identified by study of cells from
cancer patients in single families showing the same type of cancer. These
shared cancers variously showed
- similar mutant sequences in specific genes
- characteristic translocations or deletions of certain chromosomal
regions
Example: 95% of chronic myelogenous leukemia (CML) have a characteristic
translocation between chromosomes 9 and 22. (The "Philadelphia Chromosome")
Breakpoint locations:
- middle of a gene known as c-abl, a gene that normally encodes a functional
tyrosine kinase
- bcr1 gene, also coding a kinase
The translocation produces a hybrid Bcr-1-Abl protein that cannot
effect normal repressor controls on the proteins upon which normal Abl
protein acts. This results in a disruption of normal cell cycle
activity.
As you can see, a wide variety of mutations can potentially cause cancer,
and cancer cannot be considered a single "disease." It is a failure of
normal gene function.
As geneticists continue to work in the realm of FUNCTIONAL GENOMICS,
determining not only the sequence of our genes, but their function,
greater headway will be made in finally finding the answer to controlling
this genetic disorder.
(Will you be the one to find the key?)